Similarly, S-nitrosylation of HSP90 enhances its interaction with GSK-3β, leading to increased GSK-3β phosphorylation and the reduced phosphorylation of its downstream target, eIF2Bε, thereby accelerating cardiac hypertrophy [69]. The gene discussed is GSK3B; the disease is cardiac hypertrophy.